324 related articles for article (PubMed ID: 34818767)
21. Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.
Devnath P; Dhama K; Tareq AM; Emran TB
Int J Surg; 2021 Aug; 92():106031. PubMed ID: 34311126
[No Abstract] [Full Text] [Related]
22. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
Menia R; Raychaudhuri S; Agarwal C; Taneja J
Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
[TBL] [Abstract][Full Text] [Related]
23. Nasal Microbiota Imbalance as a Contributory Link in the Emergence of COVID-19 Associated Mucormycosis.
Singh R; Kumari A
ACS Infect Dis; 2021 Aug; 7(8):2211-2213. PubMed ID: 34328718
[TBL] [Abstract][Full Text] [Related]
24. A systematic review on SARS-CoV-2-associated fungal coinfections.
Soni S; Namdeo Pudake R; Jain U; Chauhan N
J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
[TBL] [Abstract][Full Text] [Related]
25. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
26. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis.
Gandra S; Ram S; Levitz SM
Ann Intern Med; 2021 Sep; 174(9):1301-1302. PubMed ID: 34097436
[TBL] [Abstract][Full Text] [Related]
27. Mucormycosis: An unanticipated progeny of COVID-19.
Shrestha GS; Bhandari S; Lamsal R; Gurung U
JNMA J Nepal Med Assoc; 2021 Sep; 59(241):965-967. PubMed ID: 35199723
[TBL] [Abstract][Full Text] [Related]
28. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
[TBL] [Abstract][Full Text] [Related]
30. COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi.
Meher R; Wadhwa V; Kumar V; Shisha Phanbuh D; Sharma R; Singh I; Rathore PK; Goel R; Arora R; Garg S; Kumar S; Kumar J; Agarwal M; Singh M; Khurana N; Sagar T; Manchanda V; Saxena S
Am J Otolaryngol; 2022; 43(1):103220. PubMed ID: 34547717
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review.
Upadhayay P; Bansal K; Goyal A
Curr Pharm Biotechnol; 2023; 24(13):1645-1656. PubMed ID: 36941816
[TBL] [Abstract][Full Text] [Related]
32. [COVID-19 associated mucormycosis. A case in Argentina].
Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
[TBL] [Abstract][Full Text] [Related]
33. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
Kamrul-Hasan AB; Selim S
Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
[TBL] [Abstract][Full Text] [Related]
34. Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.
Kulkarni R; Pujari SS; Gupta D; Ojha P; Dhamne M; Bolegave V; Dhonde P; Soni A; Adwani S; Diwan A; Duberkar D; Batra D; Deshpande R; Aurangabadkar K; Palasdeokar N
J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106231. PubMed ID: 34890962
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological association of mucormycosis in COVID 19 pandemic.
Varshney M; Saxena A; Binnani N; Kumar V; Vyas SP
Indian J Pathol Microbiol; 2023; 66(1):101-105. PubMed ID: 36656219
[TBL] [Abstract][Full Text] [Related]
36. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review.
Shah NN; Khan Z; Ahad H; Elderdery AY; Alomary MN; Atwah B; Alhindi Z; Alsugoor MH; Elkhalifa AME; Nabi S; Bashir SM; Yaqub T; Rather GA; Ansari MA
J Infect Public Health; 2022 Nov; 15(11):1299-1314. PubMed ID: 36279686
[TBL] [Abstract][Full Text] [Related]
37. Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review.
Sharma B; Nonzom S
Curr Microbiol; 2023 Aug; 80(10):322. PubMed ID: 37592083
[TBL] [Abstract][Full Text] [Related]
38. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
39. Mucormycosis and COVID-19 an epidemic in a pandemic?
Banerjee I; Robinson J; Asim M; Sathian B; Banerjee I
Nepal J Epidemiol; 2021 Jun; 11(2):1034-1039. PubMed ID: 34290893
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 associated mucormycosis surge: A review on multi-pathway mechanisms.
Pourazizi M; Hakamifard A; Peyman A; Mohammadi R; Dehghani S; Tavousi N; Hosseini NS; Azhdari Tehrani H; Abtahi-Naeini B
Parasite Immunol; 2024 Jan; 46(1):e13016. PubMed ID: 37846902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
